PEX30 Antibody

What is PEX30 and what cellular functions is it involved in?

PEX30 is an endoplasmic reticulum (ER) membrane protein that functions as an organelle-specific adaptor, enabling interactions at multiple membrane contact sites (MCSs). Research indicates that PEX30 plays significant roles in:

• Organelle budding from the endoplasmic reticulum

• Lipid droplet (LD) biogenesis in cooperation with seipin

• Formation of distinct protein complexes at the ER membrane

PEX30 belongs to a family of related proteins including PEX28, PEX29, PEX31, and PEX32, with PEX30 being the most highly expressed member of this family . Unlike other peroxins that primarily function in peroxisome formation, PEX30 appears to have broader functions at multiple organellar interfaces.

How does PEX30 interact with other family members?

PEX30 forms specific and mutually exclusive complexes with other PEX family proteins:

• PEX30 interacts with PEX28, PEX29, and PEX32 as demonstrated by co-precipitation experiments

• Despite being its closest relative, PEX31 does not interact with PEX30

• PEX30 forms a complex with PEX29 that excludes PEX28 and PEX32

• PEX30 forms a separate complex with PEX28/PEX32 that excludes PEX29

These distinct interaction patterns suggest that PEX30 participates in multiple protein complexes with specific functions at different membrane domains.

What is the most effective method for isolating PEX30-containing protein complexes?

The most effective protocol for isolating native PEX30 complexes involves:

• C-terminal tagging of PEX30 with protein A (Pex30-pA)

• Flash-freezing cells in liquid nitrogen

• Cryogenic grinding using a planetary ball mill to maintain native protein complexes

• Rapid immunoisolation using IgG-coated magnetic beads rather than IgG-Sepharose

• Careful optimization of solubilization conditions to maintain membrane protein complexes while preserving interactions

This "solid-phase" approach minimizes nonspecific protein interactions and reduces steps prior to protein complex purification, leading to more confident identification of true interacting partners .

How does PEX30 function in lipid droplet biogenesis?

PEX30 cooperates with seipin in lipid droplet biogenesis at the ER:

• While single pex30Δ mutants generally display normal lipid droplets, approximately 4% of cells show unusual Bodipy-positive structures that appear as small membranous regions

• Double mutants lacking both PEX30 and seipin components (pex30Δfld1Δ and pex30Δldb16Δ) display a unique dispersed Bodipy pattern occupying large cellular areas

• These phenotypes cannot be rescued by overexpression of other PEX30 family members (PEX28, PEX29, or PEX31), indicating a unique function for PEX30

These findings suggest that PEX30 has a partially redundant role in normal LD formation but becomes essential when the seipin complex is compromised.

Why would PEX30 function independently despite forming complexes with other family members?

This apparent contradiction can be explained by:

• Expression levels: PEX30 is significantly more abundant than other family members (PEX28, PEX29, PEX31, and PEX32)

• Complex formation: While PEX30 forms complexes with other family members, it creates mutually exclusive complexes that likely serve different functions

• Function-specific dependencies: In seipin mutants, other PEX30 family members cannot compensate for PEX30 loss, suggesting unique capabilities

The data suggest that while PEX30 participates in complexes with other family members, it has evolved specific functions related to lipid droplet formation that cannot be performed by other family members.

What controls should be included when using PEX30 antibodies for immunoprecipitation?

When performing immunoprecipitation with PEX30 antibodies, include these essential controls:

• Negative controls:

  • Immunoprecipitation in PEX30 knockout/deletion strains

  • Use of non-specific IgG antibodies with the same species origin

  • Immunoprecipitation with the specific peptide used to generate the antibody

• Validation controls:

  • Expression verification of tagged versions (e.g., PEX30-pA) before immunoprecipitation

  • Verification of protein complex integrity through independent methods

• Experimental condition controls:

  • Perform immunoprecipitation under different detergent conditions to distinguish membrane-dependent interactions

  • Include reactions without ATP to identify energy-dependent interactions

  • Conduct experiments at 4°C to minimize non-specific binding

A robust experimental design with these controls will ensure specificity and validity of detected interactions.

How can immunofluorescence protocols be optimized for PEX30 detection?

For optimal PEX30 detection using immunofluorescence:

• Fixation and permeabilization:

  • Use 4% formaldehyde fixation for 15 minutes at room temperature

  • Permeabilize with 0.1% Triton X-100 to access ER membrane proteins

• Antibody dilution optimization:

  • Test serial dilutions (typically 1:100 to 1:1000) to determine optimal signal-to-noise ratio

  • Include appropriate blocking with 5% BSA or normal serum from the secondary antibody species

• Validation strategies:

  • Use PEX30 knockout cells as negative controls

  • Co-stain with established ER markers to confirm localization

  • Compare with epitope-tagged PEX30 detected with tag-specific antibodies

• Avoiding common pitfalls:

  • Store antibodies properly to prevent degradation

  • Prevent contamination by using new plate seals for each incubation step

  • Avoid photo-bleaching by storing immunofluorescence samples in the dark

These optimizations will help ensure specific labeling of PEX30 at its native locations.

How can I address weak or no signal when detecting PEX30 by Western blot?

When troubleshooting weak or absent PEX30 signals:

• Antibody-related factors:

  • Verify antibody functionality with positive control samples

  • Consider using fresh antibody aliquots as repeated freeze-thaw cycles may reduce activity

  • Check if the antibody recognizes native or denatured forms of PEX30

• Sample preparation considerations:

  • Ensure proper membrane protein extraction using appropriate detergents

  • Avoid sample degradation by keeping samples on ice and including protease inhibitors

  • Consider enriching membrane fractions before loading

• Protocol adjustments:

  • Increase antibody concentration or incubation time

  • Use enhanced chemiluminescence detection systems

  • Test different blocking agents (BSA vs. milk) to reduce background

• Detection optimization:

  • For low abundance proteins like PEX30, increase sample loading (up to 50 μg protein)

  • Consider longer exposure times during imaging

  • Use more sensitive detection methods (e.g., HRP-conjugated secondary antibodies with enhanced substrates)

A systematic approach to these factors will help identify and resolve detection issues.

What factors affect specificity when using PEX30 antibodies?

Several factors can impact PEX30 antibody specificity:

• Antibody properties:

  • Polyclonal antibodies may recognize multiple epitopes, potentially leading to cross-reactivity

  • Antibody generation method (peptide vs. recombinant protein immunization)

  • Validation extent across different species and applications

• Experimental conditions affecting specificity:

  • Blocking solution composition (5% milk may contain cross-reactive proteins)

  • Incomplete washing leading to non-specific binding

  • Overly high antibody concentration increasing background signal

• Validation approaches:

  • Test antibody on lysates from PEX30 knockout cells

  • Pre-absorb antibody with immunizing peptide to confirm specificity

  • Validate results with a second antibody targeting a different epitope

How can PEX30 antibodies be used to study membrane contact sites?

PEX30 antibodies can provide valuable insights into membrane contact sites through:

• Proximity labeling approaches:

  • Use PEX30 antibodies in combination with APEX2 or BioID proximity labeling

  • Identify proteins in close proximity to PEX30 at different membrane contact sites

• Co-localization studies:

  • Co-stain with markers for different organelles (peroxisomes, lipid droplets, ER)

  • Quantify overlap using high-resolution microscopy to map PEX30 distribution

• Biochemical fractionation:

  • Use PEX30 antibodies to detect enrichment in different membrane fractions

  • Compare levels across different experimental conditions affecting membrane contact sites

• Immunoprecipitation of intact membrane contacts:

  • Use carefully optimized conditions that preserve membrane contacts during extraction

  • Apply PEX30 antibodies to isolate intact contact sites for proteomic analysis

These approaches leverage PEX30's position at membrane interfaces to understand the composition and dynamics of these important cellular structures.

What are the best experimental designs to study PEX30's role in mutant backgrounds?

To effectively study PEX30 in genetic backgrounds:

• Complementation strategies:

  • Express wild-type PEX30 in pex30Δ cells to confirm phenotype rescue

  • Create a series of domain mutants to identify functional regions

• Double mutant analysis:

  • Generate double mutants with related pathways (e.g., pex30Δfld1Δ)

  • Quantify synthetic phenotypes using appropriate markers (e.g., BODIPY staining for lipid droplets)

• Rescue experiments:

  • Test if overexpression of other family members can rescue mutant phenotypes

  • Use domain swap experiments to identify functional equivalency between family members

• High-resolution phenotyping:

  • Apply electron microscopy to characterize ultrastructural changes in mutants

  • Use live-cell imaging to track dynamic protein movements and organelle contacts

These experimental designs systematically dissect PEX30 function through genetic manipulation and careful phenotypic analysis.